Summary: A radioimmunoassay (RIA) without chromatography for the determination of 5a-androstan-3a,17j3-diol and of 5a-androstane-3(3,17/3-diol in human plasma by using highly specific antisera against the 15/3-carboxyethylmercapto-bovine serum albumin conjugates is described. It could be shown that the 13% cross reaction of the 5a-androstane-3/3,17/3-diol antiserum with pure androst-5-ene-3/3,17/3-diol was negligibly low in plasma extracts. Sensivity, accuracy, precision, and linearity revealed results which comply with the requisites of a reliable RIA. The plasma levels obtained were as follows (mean ± SD): 5a-androstan-3a, 17/3-diol: Normal males (N = 27) 0.86 ± 0.22 nmol/1; normal females (N = 10) 0.31 ± 0.07 nmol/1; hirsute females (N = 25) 0.60 ± 0.24 nmol/1; 5a-androstane-3/3,170-diol: Normal males 1.47 ± 0.43 nmol/1; normal females 0.49 ±0.10 nmol/1; hirsute females 0.91 ± 0.32 nmol/1.
Introduction

Material and Methods
Owing to the increasing interest in the metabolism of All reagents were analytical grade and used without further n^hydroxy-Sa-androstan-S-one in androgenic target fi^HisT-androstan-Ba, I7*diol (spec, activity 1.48 to organs, the development of a simple and specific proce-2 22 TBq/mmol) and r i, [2] [3] H]androst-5^ne-3^ 170-dioi (spec.
(Jure for the estimation of the two important metaiaictivity 1.48 to 2.22 TBq were obtained from NEN (Dreieich, bolites of 17ßihydroxy.5a-andröstan,3,one, Sarandrostan-F-R-G.). [l, [2] [3] Hi5a-androstane-3ß,17ß-diol (spec, activity
x !«/>,., Jr^ j . *a 110 ·-· 1.48 to 2.22 TBq/mmol) was purchased from Amersham-Buchler 3 , 17/tdiQl and 5a-androstane-3ß, 17/3-diol, in plasma (Braunschweig, F.R.G.). The purity of labelled steroids was Was attempted. The methods published SO far (for checked every 6 weeks. Non-labelled steroids were purchased references see discussion) need Chromatographie steps from Steraloids (Wilton, U.S.A.).
for separating cross reacting steroids. This disadvantage Antisera against the 150-carboxyethylmercapto-bovine serum was overcome by-using **& antisera raised against ^^^^^^^^^^ of Dr. Rao the 150-carboxyethylmercapto-bovine serum albumin ( §an Antonio, U.S.A.). conjugates of 5a-androstan-3a, 170-diol and 5a-androstane-A RIA was ad^pt g d for the es t ima tion of Sa-androstan-S«,!?/?-30,17/3-diol (1). The methodological details are described diol and 5ot-androstane-3^, 17^-diol in plasma. The details of the in this paper. met To 2 ml heparinized plasma, 10 ìÀ of an ethanolic solution of ( 3 H15a-androstan-3<*, 170-diol (33.3 Bq) were added, followed by an extraction with diethyl ether (10 volumes per volume). The aqueous phase was frozen at -18 °C and the ether siphoned off and evaporated under nitrogen. The residue was dissolved in 2.2 ml physiological saline and 150 ìÀ were used for the recover}' determination. Duplicate estimations of 3á-and 30-diol were performed in 500 ìÀ samples. To each 500 ìÀ specimen, 500 ìÀ of a physiological saline solution of ( 3 H|5a-androstan-3a,170-diol or (
3 H]5a-androstane-3p,17j3-diol (333 Bq), respectively, were added together with 250 ìÀ of the respective 5a-androstan-3a, 17/3-diol or 5a-androstane-30,170-diol antiserum dissolved in a solution of bovine serum albumin (1 g/1 (working titer 1:8000). The period of incubation at 4 °C was 16 hours. Separation of free and bound steroid moieties was achieved by the addition of 200 ìÀ of a charcoal/dextran solution (500 mg/100 ml charcoal; 50 mg/100 ml dextran; 100 mg/100 ml -y-globulin in physiological saline). The mixture was incubated for 20 minutes at 4 °C, and thereafter centrifuged for 6 minutes (2000 #). The supernatant was transferred into counting vials and to each sample 10 ml Insta-Gel® (Packard) were added. Scintillation counting was accomplished by means of a Betaszint-5000 (Berthold, Wildbad, F.R.G.) on-line with a Diehl Alphatronic desk computer (tolerated error less than 8%).
Standard curves were prepared in triplicate for each series of determinations, using 0 to 1500 pg of the respective non-labelled steroid ( fig. 1 and 2 ). 
Epoxidation ofandrost-5-ene-3 , 17 -diol
The method reported by Lisboa (2) was used with slight modifications. Ethanolic solutions containing 1000 pg of cold 5a-androstane-3/3,170-diol and androst-5-ene-3/3,170-dioI, respectively, were evaporated to dry ness and 1 ml of p-nitroperbenzoic acid in diethyl ether added (10 g/1). The solution was left for 17 hours at room temperature and thereafter diluted with 5 ml diethyl ether and washed by sucessive addition of 2 ml of a sodium bicarbonate solution (100 g/1), 3 X 2 ml redistilled water and 1.5 ml of a saturated NaCl solution. The diethyl ether phase was evaporated to dry ness and redissolved in physiological saline for 5ot-androstane-3j3,17/3-diol RIA as described in the foregoing section. [ 3 H)5cKindrostane-30,17|3-diol, [ 3 H)androst-5-ene-3/3,17/3-diol and mixtures of both steroids in ethanol (33.3 Bq) were brought to dry ness and treated with p-nitroperbenzoic acid in the manner described above. The final residue was separated by TLC (cyclohexane/ethyl acetate; 40-ml + 60 ml) and scanned by means of a Beta-camera (Berthold, Wildbad, F.R..G.).
Paper chromatography
In order to separate 5a-androstane-3/3,17|3rdiol and androst-5-ene-30,17 -diol, the Bush A system (heptane/methanol/water; 50 ml + 40 ml + 10 ml) was used (running time 30 h at 27 °C; Schleicher and Schull paper 2043b). The location of the steroids was achieved by labelled standards (333 Bq) placed on parallel strips and scanning with a Berthold paperscanner. The corresponding sections of the strips containing the plasma extracts were cut put and eluted with methanol. 5a-andrpstane-3/3,170-diol RIA was performed on the dried residues as outlined above.
Statistics
Statistical calculations were performed according to the Student's t-test.
Results
Specificity
The extremely high specificity of the 5a-androstan-3a, 17/kliol antiserum reported by Rao et al. (1) could be confirmed by control experiments in our laboratory. Moreover, the low cross-reaction with androsterone of 1.22% was found to be less than 1% in our experiments. The 5a-androstane-3/J, 17/3-diol antiserum also proved to be remarkably specific. The data of cross-reactions with 5o:-dihydrotestosterone (1.25%), testosterone (0.38%), oestradiol-17/3 (1.35%), and oestriol (0.11%) published by Rao et al. (1) turned out to be half as high on average. The list of tested compounds has been completed in that also the 17a-hydroxy-isomers of the androstane-diols (0.13%) and the 5á,6á epoxy derivative of 5a-androstane-3/3,17/3-diol (0%) were included. However, the cross-reaction with androst-5-ene-3/3,17/3-diol amounted to 13% in our experiments compared to 15.27% found by Rao et al (1) . Therefore, efforts have been made to remove this interfering steroid. For this purpose the epoxidation by treatment withp-nitroperbenzoic acid (2) was chosen. Excellent results were obtained with pure [ reaction which made it impossible 'to get correct displacement curves. Therefore, experiments were carried out to compare the 5a-androstane-3/3, 17/3-diol RIA with extracts from male plasma before and after separation of 5a-androstane-3/J, 17/J-diol and androst-5-ene-3/3, 17/3-diol.
The separation of the two 3/3-hydroxy-steroids by paper chromatography in the System Bush A was excellent (running distance 9.3 and 1 1 .8 cm, respectively). The results of the RIA performed with five respective plasma samples are demonstrated in table 1 . It is apparent that after chromatography the concentration of 5a-androstane-3/3, 17/3-diol was 96% of that determined "directly". This insignificant difference encouraged us to carry out the 5a-androstane-3/3, 17/3-diol RIA also without preceding chromatography. The steroid concentration eluted from the androst-5-ene-30, 170-diol spots and estimated with the 5a-androstaneO/3, 17/3-diol, an tiserum amounted to 0.03 nmol/1.
Sensitivity
The sensitivity was estimated using the formula of
were R is the percent recovery, F is the fraction of the recovered steroid used in the assay, and SD is the standard deviation of the mean of quadruplicate blank values.
The blank values for 5<*-androstan-3a, 17/3-diol RIA were ÷ 2.31 ± 4.3 pg (N -15) and the sensitivity 7.0 pg; the corresponding figures for the 5a-androstane-3/3, 17/3-diol RIA were ÷ 0.73 ± 2.2 pg and 3.0 pg. Figures 1  and 2 show the mean standard curves (± SD) for 5a-androstan-3a,17/3-and 5a-androstane-3/3, 17/3-diol, obtained from 10 different curves within a period of 8 weeks.
Accuracy
Bq of [
3 H]5a-androstan-3a,17/Hiol were added to 37 samples of preextracted female plasma. The recovery was found to be X 92.1% ± 9.05 (SD) and the coefficient of variation (CV) calculated to be 9.82%. The corresponding data for [ 3 H]5a-androstane-3/3, 17/3-diol using the same procedure were ÷ 92.9% ± 8.95; CV 9.63%. To four preextracted plasma samples, different amounts of non-labelled 5a-androstan-3a, 17/3-diol and 5a-androstane-3/3, 17/3-diol were added. The results are presented in 
Linearity
In seven different aliquots (20 to 150 ìÀ) of a male plasma pool, 5a-androstan-3o:, 17/3-diol and 5a-androstane-3/3,170-diol were estimated and revealed rectilinear curves (5a-androstan-3a, 17/3-diol: r = 0.99; 5a-androstane<3/3,17j3-diol:r = 1.01).
Plasma concentrations
The mean plasma levels obtained in normal adult male and female subjects, as well as in females with idiopathic hirsutism are compiled in table 3. The differences beTab. 3. Plasma concentrations of 5a-androstan-3a,170-diol and ScttandTQStent'Z , 17/3-diol in normal male and female subjects and in females with idiopathic hirsutism. tween males and females, and between females and hirsutes were found to be highly significant: Males versus females: 5a-androstan-3a, 17/3-diol p < 0.001; 5a-androstane-3j3,17/3-diol p < 0.001. Females vs. hirsutes: 5a-androstan-3a, 17/3-diol p < 0.01; 5a-androstane-30,17/3-diol p < 0.001. Discussion 5a-androstan-3o:, 17/3-diol
The high specificity of the 5a-androstan-3a:, 17/3-diol antiserum raised by Rao et al. (1) was confirmed. The methodological details presented fulfilled all criteria for a reliable RIA without chromatography in plasma extracts. Until now, no "direct" RIA for 5a-androstan-3a, 17/3-diol in plasma has been published. The results obtained in normal males and females correspond very well with those reported byffabrioux et al. (4) . However, the data are higher compared than those published previously by others (5,6,7) and from our laboratory (8), using different types of chromatography and less specific antisera. The reason for these differences remains obscure.
5a-androstane-3/3,17/3-diol
No "direct" RIA has been described hitherto for 5a-androstane-3/3, /3-diol in plasma. The specificity of the the 5 a-androstane-3/3,17/3-diol antiserum obtained from Rao et al.
(1) seemed to be reduced owing to crossreaction of 13% with androst-5-ene-3j3,17/3-diol, which has been estimated in male plasma in rather high concentrations ranging from 2.28 to 5.47 nmol/1 depending upon the specificity of the antiserum and the method of separation used (9, 10, 11, 12, 13) . Unfortunately, the removal of androst-5-ene-3/3,17/3-diol by epoxidation (2) gave good results only with pure steroids; but introduced unknown factors which inhibited the displacement reaction with plasma extracts. It could be shown, however, that following separation of 5a-androstane-3j3,17j8-diol and androst-5-ene-3/3, 17/3-diol by paper chromatography the difference between the figures before and after this procedure was only 4%. The 5 a-androstane-3/3,17/3-diol concentration of the androstr5-ene-3/3, 17/3-diol spots was 0.03 nmol/1. This would correspond to only 0.8% of unconjugated androst^5-ene-3/3,17/3-diol in male plasma. If the 5a-androstane-3/3,17/3-diol aritiserum of Rao et al.
(1) also exhibited a 13% cross-reaction with plasma androst-5-ene-3]3,17/3-diol, the results presented in this paper should be higher at least by 0.5 nmol/1 in males and by 0.27 nmol/1 in females. Obviously, the cross-reaction with plasma androst-5-ene-3/3,17/3-diol is negligibly low. Similar results were obtained in plasma drawn from spermatic vein (unpublished). The conclusion can be drawn that in some instances the cross-reaction of a steroid estimated with added pure steroid does not necessarily correspond with the cross^reaction of the same steroid extracted from plasma. This statement is confirmed by comparing the results described above with those reported in the literature which are markedly higher: Hopkinson et al. (14) found 2.08 and 0.97 nmol/1 of plasma 5a-androstane-3/3,17/3-diol in males and females, respectively. The corresponding data reported byHabrioux et al. (4) were 2.79 and 1.76 nmol/1. Regarding sensitivity, accuracy, precision, and linearity the 5a-androstane-3/3,17/3-diol RIA met all requirements of a reliable method. Therefore, both antisera of Rao et al.
(1) are suitable tools for a "direct" RIA of 5a-androstan-3 , 17/3-diol and 5 a-androstane-3/3,17/3-diol in human plasma.
